Literature DB >> 27436761

In Vivo Antitumor Effect of Supercritical CO2 Extract of Mango Ginger ( Curcuma amada Roxb) in U-87MG Human Glioblastoma Nude Mice Xenografts.

Cheppail Ramachandran1,2, Gilda M Portalatin2, Adriana M Prado2, Karl-Werner Quirin3, Enrique Escalon1, Steven J Melnick1,2.   

Abstract

Glioblastoma multiforme (GBM) is one the most aggressive and lethal human neoplasms with poor prognosis and very limited positive treatment options. The antitumor effect of supercritical CO2 extract of mango ginger ( Curcuma amada Roxb) (CA) with and without irinotecan (IR) was analyzed in U-87MG human glioblastoma multiforme (GBM) cells in vitro and in nude mice xenografts. CA is highly cytotoxic to GBM cells and is synergistic with IR as indicated by the combination index values of <1 in the CompuSyn analysis. CA inhibits tumor growth rate in GBM xenografts, the inhibition rate being higher than in IR treated group. GBM xenograft mice treated with IR + CA combination showed almost complete inhibition of tumor growth rate. Gene expression analysis of xenograft tumors indicated that IR + CA treatment significantly downregulated anti-apoptotic (Bcl-2 and mutant p53), inflammation-associated (COX-2) and cell division-associated (CCNB2) genes and upregulated pro-apoptotic genes (p21 and caspase-3). These results confirmed the therapeutic efficiency of IR + CA combination against GBM and the need for further clinical investigations.

Entities:  

Keywords:  Curcuma amada; gene expression; glioblastoma; mango ginger; therapeutic ratio; xenografts

Year:  2016        PMID: 27436761      PMCID: PMC5871190          DOI: 10.1177/2156587216659390

Source DB:  PubMed          Journal:  J Evid Based Complementary Altern Med        ISSN: 2156-5899


  20 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma.

Authors:  Nathalie Gaspar; Swee Y Sharp; Suzanne A Eccles; Sharon Gowan; Sergey Popov; Chris Jones; Andrew Pearson; Gilles Vassal; Paul Workman
Journal:  Mol Cancer Ther       Date:  2010-05       Impact factor: 6.261

3.  Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Authors:  René-Olivier Mirimanoff; Thierry Gorlia; Warren Mason; Martin J Van den Bent; Rolf-Dieter Kortmann; Barbara Fisher; Michele Reni; Alba A Brandes; Jüergen Curschmann; Salvador Villa; Gregory Cairncross; Anouk Allgeier; Denis Lacombe; Roger Stupp
Journal:  J Clin Oncol       Date:  2006-06-01       Impact factor: 44.544

4.  Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines.

Authors:  Govind J Kapadia; G Subba Rao; Cheppail Ramachandran; Akira Iida; Nobutaka Suzuki; Harukuni Tokuda
Journal:  J Complement Integr Med       Date:  2013-06-26

Review 5.  Multidrug resistance in brain tumors: roles of the blood-brain barrier.

Authors:  A Régina; M Demeule; A Laplante; J Jodoin; C Dagenais; F Berthelet; A Moghrabi; R Béliveau
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

6.  Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma.

Authors:  Patrick Y Wen; Antonio Omuro; Manmeet S Ahluwalia; Hassan M Fathallah-Shaykh; Nimish Mohile; Joanne J Lager; A Douglas Laird; Jiali Tang; Jason Jiang; Coumaran Egile; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2015-05-26       Impact factor: 12.300

Review 7.  Experience with irinotecan for the treatment of malignant glioma.

Authors:  James J Vredenburgh; Annick Desjardins; David A Reardon; Henry S Friedman
Journal:  Neuro Oncol       Date:  2008-09-10       Impact factor: 12.300

Review 8.  Long-term survival with glioblastoma multiforme.

Authors:  Dietmar Krex; Barbara Klink; Christian Hartmann; Andreas von Deimling; Torsten Pietsch; Matthias Simon; Michael Sabel; Joachim P Steinbach; Oliver Heese; Guido Reifenberger; Michael Weller; Gabriele Schackert
Journal:  Brain       Date:  2007-09-04       Impact factor: 13.501

9.  Complementary therapy and survival in glioblastoma.

Authors:  Bhageeradh H Mulpur; L Burt Nabors; Reid C Thompson; Jeffrey J Olson; Renato V LaRocca; Zachary Thompson; Kathleen M Egan
Journal:  Neurooncol Pract       Date:  2015-05-06

Review 10.  Characteristics of compounds that cross the blood-brain barrier.

Authors:  William A Banks
Journal:  BMC Neurol       Date:  2009-06-12       Impact factor: 2.474

View more
  2 in total

Review 1.  Chemical Composition and Biological Activities of Essential Oils of Curcuma Species.

Authors:  Noura S Dosoky; William N Setzer
Journal:  Nutrients       Date:  2018-09-01       Impact factor: 5.717

2.  Mango ginger (curcuma amada) inhibits collagen-induced arthritis by modulating inflammatory cytokine levels in rats

Authors:  Ahmet Karataş; Cemal Orhan; Mehmet Tuzcu; Nurhan Şahin; İbrahim Hanifi Özercan; Süleyman Serdar Koca; Vijaya Juturu; Kazim Şahin
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.